Imjudo-Imfinzi Regimen Improves Survival With Manageable Side Effects in Liver Cancer Subset
June 3rd 2023Patients with unresectable hepatocellular carcinoma treated with the STRIDE regimen, consisting of Imjudo and Imfinzi, experienced manageable immune-related side effects with improvements in overall survival.